
Gefapixant citrate is a P2X3 антагонист currently studied for use in the treatment of disorders associated with purinergic рецептор activation.
Gefapixant citrate is a P2X3 antagonist currently studied for use in the treatment of disorders associated with purinergic receptor activation.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.